126 related articles for article (PubMed ID: 7917342)
1. Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents.
Vuille C; Nidorf M; Morrissey RL; Newell JB; Weyman AE; Picard MH
J Am Soc Echocardiogr; 1994; 7(4):347-54. PubMed ID: 7917342
[TBL] [Abstract][Full Text] [Related]
2. Pulsatile pressure affects the disappearance of echocardiographic contrast agents.
Padial LR; Chen MH; Vuille C; Guerrero JL; Weyman AE; Picard MH
J Am Soc Echocardiogr; 1995; 8(3):285-92. PubMed ID: 7640022
[TBL] [Abstract][Full Text] [Related]
3. Myocardial risk area and peak gray level measurement by contrast echocardiography: effect of microbubble size and concentration, injection rate, and coronary vasodilation.
Vandenberg BF; Feinstein SB; Kieso RA; Hunt M; Kerber RE
Am Heart J; 1988 Apr; 115(4):733-9. PubMed ID: 3354401
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
Hasegawa M; Saiki Y; Kayano H; Katagiri T
Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
[TBL] [Abstract][Full Text] [Related]
5. Suitable solutions for reconstituting the ultrasound contrast agent "Levovist" used in contrast echocardiogram: in vitro and in vivo evaluation of the influence of osmotic pressure.
Shiina Y; Funabashi N; Teramoto K; Uehara M; Takaoka H; Mikami Y; Takahashi A; Saito M; Daimon M; Lee K; Kawakubo M; Sekine Y; Takahashi M; Yajima R; Tani A; Komuro I
Int J Cardiol; 2009 Aug; 136(3):335-40. PubMed ID: 18678422
[TBL] [Abstract][Full Text] [Related]
6. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
Bouakaz A; de Jong N; Cachard C; Jouini K
Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
[TBL] [Abstract][Full Text] [Related]
7. Measurements of the nonlinearity parameter B/A of contrast agents.
Wu J; Tong J
Ultrasound Med Biol; 1998 Jan; 24(1):153-9. PubMed ID: 9483783
[TBL] [Abstract][Full Text] [Related]
8. Effect of pressure on echocardiographic videodensity from sonicated albumin: an in vitro model.
Gottlieb S; Ernst A; Meltzer RS
J Ultrasound Med; 1995 Feb; 14(2):109-16. PubMed ID: 8568955
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound contrast agents nucleate inertial cavitation in vitro.
Miller DL; Thomas RM
Ultrasound Med Biol; 1995; 21(8):1059-65. PubMed ID: 8553500
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of two air-based contrast agents in dogs.
Uchimoto R; Niwa K; Tsuda N; Miyazawa T; Bräutigam M
Eur J Ultrasound; 2000 May; 11(2):127-33. PubMed ID: 10781661
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of mitral flow assessment by echo-contrast ultrasound, part I: determination of the properties of echo-contrast agents.
Herman B; Einav S; Vered Z
Ultrasound Med Biol; 2000 Jun; 26(5):787-95. PubMed ID: 10942826
[TBL] [Abstract][Full Text] [Related]
12. Acoustic lability of albumin microspheres.
Vandenberg BF; Melton HE
J Am Soc Echocardiogr; 1994; 7(6):582-9. PubMed ID: 7840985
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional contrast echocardiography. II. Transpulmonary studies.
Ten Cate FJ; Feinstein S; Zwehl W; Meerbaum S; Fishbein M; Shah PM; Corday E
J Am Coll Cardiol; 1984 Jan; 3(1):21-7. PubMed ID: 6690551
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracoronary injections of sonicated microbubbles on left ventricular contractility.
Lang RM; Borow KM; Neumann A; Al-Sadir J; Feinstein SB
Am J Cardiol; 1987 Jul; 60(1):166-71. PubMed ID: 3604933
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic contrast agents and left ventricular contractility: evaluation using an isolated rabbit heart model.
Mor-Avi V; Shroff SG; Robinson KA; Cholley BP; Ng AF; Lang RM
J Am Soc Echocardiogr; 1996; 9(4):452-61. PubMed ID: 8827628
[TBL] [Abstract][Full Text] [Related]
16. Optimal Albunex dosing for enhancement of Doppler tricuspid regurgitation spectra.
Kemp WE; Kerins DM; Shyr Y; Byrd BF
Am J Cardiol; 1997 Jan; 79(2):232-4. PubMed ID: 9193036
[TBL] [Abstract][Full Text] [Related]
17. Destruction of contrast microbubbles during ultrasound imaging at conventional power output.
Villarraga HR; Foley DA; Aeschbacher BC; Klarich KW; Mulvagh SL
J Am Soc Echocardiogr; 1997 Oct; 10(8):783-91. PubMed ID: 9356941
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
19. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
20. Contrast echocardiography in coronary artery diseased patients: effect of systemic and pulmonary artery pressures on left heart opacification after intravenous injection of Albunex.
Geny B; Piquard F; Muan B; Epailly E; Lambrechs M; Thiranos JC; Petit H; Eisenmann B; Haberey P
Coron Artery Dis; 1997 Feb; 8(2):77-81. PubMed ID: 9211046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
